Protein Kinase Cδ Promotes Transitional B Cell-Negative Selection and Limits Proximal B Cell Receptor Signaling To Enforce Tolerance

REFERENCES

• Mecklenbrauker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A. 2002. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416:860–865. http://dx.doi.org/10.1038/416860a.
   PubMedGoogle Scholar
• Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, Nakayama KI. 2002. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416:865–869. http://dx.doi.org/10.1038/416865a.
   PubMed Web of Science ®Google Scholar
• Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS, Daly SB, Dickerson JE, Mayer J, O'Sullivan J, Juillard L, Urquhart JE, Fawdar S, Marusiak AA, Stephenson N, Waszkowycz B, Beresford M, Biesecker LG, Black G, Rene C, Eliaou JF, Fabien N, Ranchin B, Cochat P, Gaffney PM, Rozenberg F, Lebon P, Malcus C, Crow YJ, Brognard J, Bonnefoy N. 2013. Protein kinase Cdelta deficiency causes Mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 65:2161–2171. http://dx.doi.org/10.1002/art.38008.
   PubMed Web of Science ®Google Scholar
• Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB, Park CL, Fleisher TA, Uzel G, Oliveira JB. 2013. Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans. Blood 121:3117–3125. http://dx.doi.org/10.1182/blood-2012-12-469544.
   PubMed Web of Science ®Google Scholar
• Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, Garncarz W, Mullauer L, Kain R, Boztug H, Heitger A, Arbeiter K, Eitelberger F, Seidel MG, Holter W, Pollak A, Pickl WF, Forster-Waldl E, Boztug K. 2013. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C delta. Blood 121:3112–3116. http://dx.doi.org/10.1182/blood-2012-10-460741.
   PubMed Web of Science ®Google Scholar
• Conrad FJ, Rice JS, Cambier JC. 2007. Multiple paths to loss of anergy and gain of autoimmunity. Autoimmunity 40:418–424. http://dx.doi.org/10.1080/08916930701464723.
   PubMed Web of Science ®Google Scholar
• Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. 2003. Predominant autoantibody production by early human B cell precursors. Science 301:1374–1377. http://dx.doi.org/10.1126/science.1086907.
   PubMed Web of Science ®Google Scholar
• Yurasov S, Nussenzweig MC. 2007. Regulation of autoreactive antibodies. Curr. Opin. Rheumatol. 19:421–426. http://dx.doi.org/10.1097/BOR.0b013e328277ef3b.
   PubMedGoogle Scholar
• Yurasov S, Tiller T, Tsuiji M, Velinzon K, Pascual V, Wardemann H, Nussenzweig MC. 2006. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 203:2255–2261. http://dx.doi.org/10.1084/jem.20061446.
   PubMed Web of Science ®Google Scholar
• Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201:703–711. http://dx.doi.org/10.1084/jem.20042251.
   PubMed Web of Science ®Google Scholar
• Su TT, Guo B, Wei B, Braun J, Rawlings DJ. 2004. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197:161–178. http://dx.doi.org/10.1111/j.0105-2896.2004.0102.x.
   PubMed Web of Science ®Google Scholar
• Su TT, Rawlings DJ. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168:2101–2110.
   PubMed Web of Science ®Google Scholar
• Pillai S. 1999. The chosen few? Positive selection and the generation of naive B lymphocytes. Immunity 10:493–502.
   PubMedGoogle Scholar
• Pillai S, Cariappa A. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9:767–777. http://dx.doi.org/10.1038/nri2656.
   PubMed Web of Science ®Google Scholar
• Pillai S, Cariappa A, Moran ST. 2004. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 197:206–218. http://dx.doi.org/10.1111/j.0105-2896.2003.097.x.
   PubMed Web of Science ®Google Scholar
• Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676–682. http://dx.doi.org/10.1038/334676a0.
   PubMed Web of Science ®Google Scholar
• Zikherman J, Parameswaran R, Weiss A. 2012. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489:160–164. http://dx.doi.org/10.1038/nature11311.
   PubMedGoogle Scholar
• Cambier JC, Gauld SB, Merrell KT, Vilen BJ. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7:633–643. http://dx.doi.org/10.1038/nri2133.
   PubMed Web of Science ®Google Scholar
• Lam KP, Kuhn R, Rajewsky K. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073–1083. http://dx.doi.org/10.1016/S0092-8674(00)80373-6.
   PubMed Web of Science ®Google Scholar
• Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20:441–453. http://dx.doi.org/10.1016/S1074-7613(04)00079-2.
   PubMed Web of Science ®Google Scholar
• Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20:785–798. http://dx.doi.org/10.1016/j.immuni.2004.05.010.
   PubMed Web of Science ®Google Scholar
• Claudio E, Brown K, Park S, Wang H, Siebenlist U. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958–965. http://dx.doi.org/10.1038/ni842.
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM. 2002. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17:515–524. http://dx.doi.org/10.1016/S1074-7613(02)00425-9.
   PubMed Web of Science ®Google Scholar
• Schweighoffer E, Vanes L, Nys J, Cantrell D, McCleary S, Smithers N, Tybulewicz VL. 2013. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 38:475–488. http://dx.doi.org/10.1016/j.immuni.2012.11.015.
   PubMedGoogle Scholar
• Mecklenbrauker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A. 2004. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431:456–461. http://dx.doi.org/10.1038/nature02955.
   PubMedGoogle Scholar
• Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T, Roose JP, Weiss A. 2011. STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat. Immunol. 12:425–433. http://dx.doi.org/10.1038/ni.2016.
   PubMed Web of Science ®Google Scholar
• Zikherman J, Doan K, Parameswaran R, Raschke W, Weiss A. 2012. Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. Proc. Natl. Acad. Sci. U. S. A. 109:E3–E12. http://dx.doi.org/10.1073/pnas.1117374108.
   PubMedGoogle Scholar
• Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042–2045. http://dx.doi.org/10.1126/science.281.5385.2042.
   PubMed Web of Science ®Google Scholar
• Rybin VO, Sabri A, Short J, Braz JC, Molkentin JD, Steinberg SF. 2003. Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. Role of PKC epsilon in activation loop phosphorylations and PKC delta in hydrophobic motif phosphorylations. J. Biol. Chem. 278:14555–14564.
   PubMedGoogle Scholar
• Stempka L, Schnolzer M, Radke S, Rincke G, Marks F, Gschwendt M. 1999. Requirements of protein kinase cdelta for catalytic function. Role of glutamic acid 500 and autophosphorylation on serine 643. J. Biol. Chem. 274:8886–8892.
   PubMedGoogle Scholar
• Yamamoto N, Takeshita K, Shichijo M, Kokubo T, Sato M, Nakashima K, Ishimori M, Nagai H, Li YF, Yura T, Bacon KB. 2003. The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. J. Pharmacol. Exp. Ther. 306:1174–1181. http://dx.doi.org/10.1124/jpet.103.052316.
   PubMed Web of Science ®Google Scholar
• Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497–508. http://dx.doi.org/10.1016/S1074-7613(00)80554-3.
   PubMed Web of Science ®Google Scholar
• Gross AJ, Lyandres JR, Panigrahi AK, Prak ET, DeFranco AL. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182:5382–5392. http://dx.doi.org/10.4049/jimmunol.0803941.
   PubMedGoogle Scholar
• Gross AJ, Proekt I, DeFranco AL. 2011. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur. J. Immunol. 41:3645–3655. http://dx.doi.org/10.1002/eji.201141708.
   PubMed Web of Science ®Google Scholar
• Limnander A, Weiss A. 2011. Ca-dependent Ras/Erk signaling mediates negative selection of autoreactive B cells. Small GTPases 2:282–288. http://dx.doi.org/10.4161/sgtp.2.5.17794.
   PubMedGoogle Scholar